Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on June 3, 2026

Jun. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 3, 2026

79% of Enterprises Are Confident They Can Scale AI Without Breaking Governance. Only 29% Can Even Find the Data.

Indeterminate GlobeNewswire

Jun. 3, 2026

DMW&H Achieves SOC 2® Compliance Milestone

Indeterminate GlobeNewswire

Jun. 3, 2026

FactSet Schedules Third Quarter 2026 Earnings Call

Indeterminate GlobeNewswire

Jun. 3, 2026

SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer

Indeterminate GlobeNewswire

Jun. 3, 2026

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Indeterminate GlobeNewswire

Jun. 3, 2026

Joveo Introduces AI Talent Campaigns to Help Recruiters Launch Multi-Touch Outreach in Minutes

Indeterminate GlobeNewswire

Jun. 3, 2026

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Indeterminate GlobeNewswire

Jun. 3, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 3, 2026

Emerita Announces Appointments of New Independent Director and Corporate Secretary

Indeterminate GlobeNewswire

Jun. 3, 2026

Highland Copper Identifies Key Optimization Opportunities Through Detailed Engineering at the Copperwood Project

Indeterminate GlobeNewswire

Jun. 3, 2026

Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jun. 3, 2026

Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms

Indeterminate GlobeNewswire

Jun. 3, 2026

Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China

Indeterminate GlobeNewswire

Jun. 3, 2026

Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 3, 2026

Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy

Indeterminate GlobeNewswire

Jun. 3, 2026

Aptean Appoints Yama Habibzai as Chief Marketing Officer

Indeterminate GlobeNewswire

Jun. 3, 2026

A.I.S. Resources Announces Grant of Options

Indeterminate GlobeNewswire

Jun. 3, 2026

Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study

Indeterminate GlobeNewswire